{"nct_id":"NCT05372419","title":"A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color","status":"COMPLETED","status_verified_date":"2025-06","start_date":"2023-01-12","start_date_type":"ACTUAL","primary_completion_date":"2024-05-03","primary_completion_date_type":"ACTUAL","completion_date":"2025-02-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}